Key Insights
The global Assisted Reproductive Technology (ART) market is poised for significant expansion, projected to reach $37.21 billion in 2025. This robust growth is fueled by an increasing prevalence of infertility worldwide, driven by factors such as delayed childbearing, lifestyle changes, and rising environmental concerns. The market is expected to witness a healthy Compound Annual Growth Rate (CAGR) of 8.3% throughout the forecast period of 2025-2033. Key technologies such as In Vitro-fertilization (IVF) continue to dominate the market, offering higher success rates and becoming more accessible. Artificial Insemination (AI-IUI) and Frozen Embryo Replacement (FER) also represent substantial segments, catering to diverse patient needs and preferences. The increasing demand for fertility treatments across hospitals and specialized fertility clinics underscores the growing acceptance and integration of ART into mainstream healthcare. Furthermore, advancements in genetic screening techniques and cryopreservation methods are enhancing the efficacy and safety of ART procedures, thereby bolstering market confidence and adoption.
Assisted Reproductive Technology Industry Market Size (In Billion)
Several factors are propelling the ART market forward. A significant driver is the growing awareness and de-stigmatization of fertility treatments, encouraging more individuals and couples to seek professional assistance. Government initiatives and insurance coverage expansion in various regions are also playing a crucial role in improving affordability and accessibility. Technological innovations, including the development of more sophisticated laboratory equipment and improved success rates in embryo implantation, are also contributing to market dynamism. However, the market faces certain restraints, such as the high cost of ART procedures, which can be a barrier for many. Ethical and regulatory concerns surrounding ART also present challenges. Despite these hurdles, the upward trend in infertility rates and the continuous pursuit of parenthood are expected to sustain the upward trajectory of the ART market, making it a critical and rapidly evolving sector in global healthcare.
Assisted Reproductive Technology Industry Company Market Share
Assisted Reproductive Technology Industry Market Analysis Report
This comprehensive report delves into the dynamic Assisted Reproductive Technology (ART) industry, providing an in-depth analysis of market concentration, innovation drivers, industry trends, dominant segments, product developments, and strategic outlook. Covering a study period from 2019 to 2033, with a base and estimated year of 2025 and a forecast period of 2025–2033, this report offers actionable insights for industry stakeholders. The global ART market is projected to reach multi-billion dollar valuations, driven by increasing infertility rates, advancements in medical technology, and growing awareness.
Assisted Reproductive Technology Industry Market Concentration & Innovation
The Assisted Reproductive Technology (ART) industry exhibits a moderate to high level of market concentration, with a mix of established global players and emerging regional specialists. Innovation is a critical driver, fueled by continuous research and development in areas such as genetic screening, novel drug delivery systems, and improved laboratory techniques. Regulatory frameworks, while essential for patient safety, can also influence market entry and innovation speed. Product substitutes, such as improved lifestyle choices and natural conception methods, exist but are increasingly overshadowed by the efficacy of ART for individuals facing significant fertility challenges. End-user trends indicate a growing demand for personalized and holistic reproductive care, moving beyond simple treatment to encompass emotional and psychological support. Mergers and acquisitions (M&A) are significant, with deal values in the hundreds of millions to billions of dollars, as companies seek to expand their geographical reach, acquire cutting-edge technologies, and consolidate market share. For instance, strategic partnerships and acquisitions aimed at integrating diagnostics, treatment, and cryopreservation services are becoming prevalent.
- Key Drivers of Innovation:
- Advancements in embryology and genetic testing (e.g., PGT-A, PGT-M).
- Development of new pharmaceuticals for ovarian stimulation and luteal support.
- Improved cryopreservation techniques for gametes and embryos.
- Integration of artificial intelligence and machine learning in embryo selection and treatment planning.
- M&A Activity Focus:
- Acquisition of specialized fertility clinics and IVF centers.
- Investment in companies developing novel ART devices and consumables.
- Consolidation of cryopreservation services.
Assisted Reproductive Technology Industry Industry Trends & Insights
The Assisted Reproductive Technology (ART) industry is experiencing robust growth, propelled by a confluence of demographic, technological, and socioeconomic factors. A significant market penetration is being observed across developed and developing economies, with the global market size projected to reach several hundred billion dollars by 2033. The compound annual growth rate (CAGR) is estimated to be in the high single digits to low double digits over the forecast period. Key growth drivers include the rising incidence of infertility, attributed to factors such as delayed childbearing, lifestyle choices, environmental influences, and increasing awareness of available treatment options. Technological disruptions are at the forefront, with continuous innovation in IVF technologies, gamete cryopreservation, and preimplantation genetic testing (PGT) enhancing success rates and expanding treatment possibilities. Consumer preferences are evolving towards more personalized and patient-centric approaches, demanding higher success rates, reduced multiple pregnancies, and greater accessibility to treatment. The competitive landscape is characterized by intense R&D efforts, strategic alliances, and a focus on improving patient outcomes and affordability. The expanding reach of ART services into emerging markets, coupled with favorable government initiatives and increased insurance coverage in some regions, further fuels market expansion. The demographic shift towards later parenthood globally is a persistent driver, necessitating ART for a growing segment of the population.
- Market Growth Drivers:
- Increasing global infertility rates.
- Delayed childbearing trends.
- Technological advancements and improved success rates.
- Growing awareness and acceptance of ART.
- Favorable government policies and increasing insurance coverage in select regions.
- Technological Disruptions:
- AI-driven embryo selection and risk prediction.
- Minimally invasive surgical techniques for fertility preservation.
- Advanced genetic screening technologies.
- Development of novel gamete and embryo culture media.
- Consumer Preferences:
- Demand for higher success rates and lower multiple birth rates.
- Preference for single embryo transfer.
- Increased interest in genetic testing for reproductive health.
- Desire for a more personalized and supportive patient journey.
- Competitive Dynamics:
- Strategic partnerships between technology providers and fertility clinics.
- Acquisitions to gain market share and access new technologies.
- Focus on cost-effectiveness and value-based care.
- Intensified R&D to develop next-generation ART solutions.
Dominant Markets & Segments in Assisted Reproductive Technology Industry
The Assisted Reproductive Technology (ART) industry demonstrates significant regional and segment-specific dominance. North America, particularly the United States, along with Europe, currently holds the largest market share due to established healthcare infrastructures, high disposable incomes, advanced technological adoption, and a relatively higher prevalence of delayed childbearing. Asia-Pacific is emerging as a rapidly growing market, driven by increasing awareness, a burgeoning middle class, and government initiatives to address declining birth rates in some countries. Within the technology segments, In Vitro-Fertilization (IVF) represents the largest and most dominant segment, accounting for a substantial portion of the total ART market. This is attributed to its high success rates, comprehensive treatment approach, and continuous technological refinements. Artificial Insemination (AI-IUI) is another significant segment, particularly for less complex fertility issues, offering a more affordable and less invasive option. Frozen Embryo Replacement (FER) is gaining prominence as cryopreservation technologies improve, allowing for greater flexibility and reducing the need for multiple fresh embryo transfers.
- Dominant Regions & Countries:
- North America: High per capita spending on healthcare, advanced technology adoption, and strong regulatory support for fertility treatments.
- Europe: Robust healthcare systems, growing awareness, and increasing government funding for ART services in several countries.
- Asia-Pacific: Rapid market expansion driven by increasing disposable incomes, rising infertility rates, and supportive government policies in countries like China and India.
- Dominant Segments - Technology:
- In Vitro-Fertilization (IVF):
- Key Drivers: High success rates, comprehensive approach to infertility, continuous technological advancements (e.g., ICSI, genetic screening).
- Dominance Analysis: Continues to be the cornerstone of ART, with ongoing innovations enhancing its efficacy and appeal to a broader patient base. The complexity and cost of IVF treatments contribute to its significant market value.
- Artificial Insemination (AI-IUI):
- Key Drivers: Lower cost, less invasive procedure, suitable for specific types of infertility.
- Dominance Analysis: Remains a widely utilized and accessible option, particularly in regions where advanced IVF treatments may be cost-prohibitive or for patients with less severe fertility challenges.
- Frozen Embryo Replacement (FER):
- Key Drivers: Improved cryopreservation techniques, ability to delay embryo transfer, reduced risk of OHSS, cost-effectiveness for multiple cycles.
- Dominance Analysis: Its share is steadily increasing as success rates for frozen embryo transfers now rival or exceed fresh transfers, offering greater patient convenience and optimizing resource utilization.
- In Vitro-Fertilization (IVF):
- Dominant Segments - End Users:
- Fertility Clinics:
- Key Drivers: Specialized expertise, comprehensive service offerings, dedicated patient care, focus on advanced ART procedures.
- Dominance Analysis: These dedicated facilities are the primary service providers, equipped with the latest technology and staffed by experienced professionals, making them the leading end-users of ART products and services.
- Hospitals:
- Key Drivers: Integrated healthcare services, access to a broader patient population, ability to handle complex cases and co-morbidities.
- Dominance Analysis: While specialized fertility clinics dominate, hospitals with dedicated obstetrics and gynecology departments, and those offering comprehensive reproductive health services, represent a significant and growing end-user base for ART.
- Fertility Clinics:
Assisted Reproductive Technology Industry Product Developments
Product developments in the ART industry are revolutionizing fertility treatments, offering enhanced precision and improved outcomes. Innovations range from next-generation culture media that optimize embryo development to advanced imaging systems for gamete selection and novel genetic testing platforms for comprehensive chromosomal and gene analysis. The competitive advantage lies in products that can demonstrably increase success rates, reduce the risk of complications like multiple pregnancies, and provide a more personalized patient experience. The integration of AI in devices for automated embryo assessment and improved cryopreservation techniques further solidifies the market position of companies leading these technological advancements.
Report Scope & Segmentation Analysis
This report segments the global Assisted Reproductive Technology (ART) industry based on technology and end-users. The technology segmentation includes In Vitro-Fertilization (IVF), Artificial Insemination (AI-IUI), Frozen Embryo Replacement (FER), and Others, which encompasses techniques like Gamete Intrafallopian Transfer (GIFT) and Zygote Intrafallopian Transfer (ZIFT). The end-user segmentation covers Hospitals and Fertility Clinics. Each segment is analyzed for its market size, growth projections, and competitive dynamics. IVF is projected to maintain its dominant position, followed by AI-IUI and FER, with the "Others" segment representing a smaller but niche market. Fertility clinics are expected to continue leading in terms of service provision and adoption of advanced ART.
- Technology Segments:
- In Vitro-Fertilization (IVF): Projected to exhibit strong growth, driven by continuous technological advancements and increasing demand.
- Artificial Insemination (AI-IUI): Expected to maintain a steady growth trajectory, offering a cost-effective solution for many patients.
- Frozen Embryo Replacement (FER): Anticipated to witness significant growth due to improving cryopreservation success rates.
- Others: A smaller segment, likely to see niche growth in specific applications.
- End-User Segments:
- Hospitals: Expected to see moderate growth as they expand their reproductive health services.
- Fertility Clinics: Projected to be the dominant end-user segment, driven by specialization and adoption of cutting-edge ART.
Key Drivers of Assisted Reproductive Technology Industry Growth
The Assisted Reproductive Technology (ART) industry's growth is propelled by a synergistic interplay of technological, economic, and regulatory factors. Technologically, continuous advancements in IVF techniques, genetic screening, and cryopreservation are significantly improving success rates and expanding treatment options. Economically, rising disposable incomes in emerging markets and increasing insurance coverage for fertility treatments in developed nations are enhancing affordability and accessibility. Regulatory frameworks, while sometimes posing challenges, also drive growth by ensuring quality standards and promoting ethical practices, which builds patient trust. Furthermore, the increasing prevalence of lifestyle-related infertility and the societal trend of delayed childbearing are creating a sustained demand for ART services, making it a crucial pillar of modern reproductive healthcare.
- Technological Advancements: Breakthroughs in embryology, genetic diagnostics, and cryopreservation.
- Economic Factors: Rising disposable incomes, increased insurance coverage, and government incentives.
- Societal Trends: Delayed childbearing, increasing awareness of infertility, and demand for family planning solutions.
Challenges in the Assisted Reproductive Technology Industry Sector
Despite its robust growth, the Assisted Reproductive Technology (ART) industry faces several significant challenges. High treatment costs remain a substantial barrier for many individuals, limiting access to services, particularly in regions with limited insurance coverage. Stringent and evolving regulatory landscapes across different countries can create complexities in market entry and product approval processes. Ethical considerations surrounding embryo selection, genetic screening, and the use of donor gametes also present ongoing debates and necessitate careful navigation. Furthermore, the supply chain for specialized consumables and equipment can be susceptible to disruptions, impacting the availability and cost of essential ART components. The competitive pressure to maintain high success rates while managing costs also poses a continuous challenge for service providers.
- High Treatment Costs: Limiting affordability and accessibility for a significant patient population.
- Regulatory Hurdles: Complex and evolving regulations across different geographies impacting market entry and innovation.
- Ethical Considerations: Debates surrounding genetic screening, embryo selection, and donor gametes.
- Supply Chain Vulnerabilities: Potential disruptions impacting the availability and cost of essential ART materials.
Emerging Opportunities in Assisted Reproductive Technology Industry
The Assisted Reproductive Technology (ART) industry is brimming with emerging opportunities, driven by evolving consumer preferences and technological breakthroughs. The growing demand for personalized medicine and advanced genetic diagnostics presents a significant avenue for innovation, enabling tailored treatment plans and improved patient outcomes. The expansion of ART services into underserved geographical markets, particularly in developing economies, offers substantial growth potential. Furthermore, advancements in artificial intelligence and machine learning are paving the way for more efficient embryo selection, risk prediction, and optimized treatment protocols. The increasing interest in fertility preservation for medical or personal reasons also opens new market segments. Collaborative efforts between technology developers, clinics, and research institutions can accelerate the development and adoption of novel ART solutions, ultimately increasing accessibility and success rates globally.
- Personalized Medicine: Tailored treatments based on genetic profiling and individual patient needs.
- Emerging Markets: Expanding ART services to regions with growing demand and limited current access.
- AI and Machine Learning: Leveraging data analytics for improved treatment efficacy and predictive capabilities.
- Fertility Preservation: Growing demand for egg, sperm, and embryo freezing services.
Leading Players in the Assisted Reproductive Technology Industry Market
- Microm Ltd
- Ferring B.V.
- Hamilton Thorne Inc.
- FUJIFILM Irvine Scientific Inc.
- OvaScience Inc.
- Esco Medical
- Memmert GmbH + Co. KG
- CooperSurgical Inc.
- Nidacon International AB
- Laboratoire CCD
- Vitrolife
- Bloom IVF Centre
Key Developments in Assisted Reproductive Technology Industry Industry
- February 2023: Bumrungrad International Hospital launched its Fertility Center & IVF Clinic, which delivers holistic reproductive care, from consultation to assisted reproductive technology (ART), for families wanting to conceive.
- June 2022: Inception Fertility expanded its ecosystem to include the launch of HavenCryo, a long-term reproductive tissue and cryopreservation storage solution that offers a unique experience for fertility providers and patients. It includes technology for assisted reproductive technologies (ART).
- March 2022: CK Birla Healthcare launched its flagship fertility clinic, Birla Fertility, in New Delhi with assisted reproductive technology (ART).
Strategic Outlook for Assisted Reproductive Technology Industry Market
The strategic outlook for the Assisted Reproductive Technology (ART) industry remains exceptionally positive, driven by a persistent global demand for fertility solutions and continuous innovation. The market is poised for sustained growth, with a focus on enhancing success rates, reducing costs, and broadening accessibility. Key growth catalysts include the integration of advanced technologies like AI, personalized genomics, and improved cryopreservation techniques, which will further refine treatments and patient experiences. Strategic partnerships and consolidations will likely continue to shape the competitive landscape, enabling companies to offer comprehensive service portfolios and expand their global footprint. Emphasis on patient-centric care, ethical practices, and addressing unmet needs will be crucial for long-term success. The expanding reach into emerging economies, coupled with increasing awareness and supportive policies, presents significant untapped potential, positioning the ART market as a vital and growing sector within global healthcare.
Assisted Reproductive Technology Industry Segmentation
-
1. Technology
- 1.1. In Vitro-fertilization (IVF)
- 1.2. Artificial Insemination (AI-IUI)
- 1.3. Frozen Embryo Replacement (FER)
- 1.4. Others
-
2. End Users
- 2.1. Hospital
- 2.2. Fertility Clinics
Assisted Reproductive Technology Industry Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America
Assisted Reproductive Technology Industry Regional Market Share
Geographic Coverage of Assisted Reproductive Technology Industry
Assisted Reproductive Technology Industry REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 8.3% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Number of Infertility Cases; Rise in Number of Single Women and Same-sex Couples; Increase in Awareness for IVF and Surrogacy
- 3.3. Market Restrains
- 3.3.1. High Cost and Socio-ethical Issues; Changing Government Regulations
- 3.4. Market Trends
- 3.4.1. In-Vitro Fertilization (IVF) Segment is Expected to Grow Significantly During the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Assisted Reproductive Technology Industry Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Technology
- 5.1.1. In Vitro-fertilization (IVF)
- 5.1.2. Artificial Insemination (AI-IUI)
- 5.1.3. Frozen Embryo Replacement (FER)
- 5.1.4. Others
- 5.2. Market Analysis, Insights and Forecast - by End Users
- 5.2.1. Hospital
- 5.2.2. Fertility Clinics
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. Middle East and Africa
- 5.3.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Technology
- 6. North America Assisted Reproductive Technology Industry Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Technology
- 6.1.1. In Vitro-fertilization (IVF)
- 6.1.2. Artificial Insemination (AI-IUI)
- 6.1.3. Frozen Embryo Replacement (FER)
- 6.1.4. Others
- 6.2. Market Analysis, Insights and Forecast - by End Users
- 6.2.1. Hospital
- 6.2.2. Fertility Clinics
- 6.1. Market Analysis, Insights and Forecast - by Technology
- 7. Europe Assisted Reproductive Technology Industry Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Technology
- 7.1.1. In Vitro-fertilization (IVF)
- 7.1.2. Artificial Insemination (AI-IUI)
- 7.1.3. Frozen Embryo Replacement (FER)
- 7.1.4. Others
- 7.2. Market Analysis, Insights and Forecast - by End Users
- 7.2.1. Hospital
- 7.2.2. Fertility Clinics
- 7.1. Market Analysis, Insights and Forecast - by Technology
- 8. Asia Pacific Assisted Reproductive Technology Industry Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Technology
- 8.1.1. In Vitro-fertilization (IVF)
- 8.1.2. Artificial Insemination (AI-IUI)
- 8.1.3. Frozen Embryo Replacement (FER)
- 8.1.4. Others
- 8.2. Market Analysis, Insights and Forecast - by End Users
- 8.2.1. Hospital
- 8.2.2. Fertility Clinics
- 8.1. Market Analysis, Insights and Forecast - by Technology
- 9. Middle East and Africa Assisted Reproductive Technology Industry Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Technology
- 9.1.1. In Vitro-fertilization (IVF)
- 9.1.2. Artificial Insemination (AI-IUI)
- 9.1.3. Frozen Embryo Replacement (FER)
- 9.1.4. Others
- 9.2. Market Analysis, Insights and Forecast - by End Users
- 9.2.1. Hospital
- 9.2.2. Fertility Clinics
- 9.1. Market Analysis, Insights and Forecast - by Technology
- 10. South America Assisted Reproductive Technology Industry Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Technology
- 10.1.1. In Vitro-fertilization (IVF)
- 10.1.2. Artificial Insemination (AI-IUI)
- 10.1.3. Frozen Embryo Replacement (FER)
- 10.1.4. Others
- 10.2. Market Analysis, Insights and Forecast - by End Users
- 10.2.1. Hospital
- 10.2.2. Fertility Clinics
- 10.1. Market Analysis, Insights and Forecast - by Technology
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 Microm Ltd
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Ferring B V
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Hamilton Thorne Inc
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 FUJIFILM Irvine Scientific Inc
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 OvaScience Inc
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Esco Medical
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Memmert GmbH + Co KG*List Not Exhaustive
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 CooperSurgical Inc
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 Nidacon International AB
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Laboratoire CCD
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 Vitrolife
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.12 Bloom IVF Centre
- 11.2.12.1. Overview
- 11.2.12.2. Products
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Financials (Based on Availability)
- 11.2.1 Microm Ltd
List of Figures
- Figure 1: Global Assisted Reproductive Technology Industry Revenue Breakdown (billion, %) by Region 2025 & 2033
- Figure 2: North America Assisted Reproductive Technology Industry Revenue (billion), by Technology 2025 & 2033
- Figure 3: North America Assisted Reproductive Technology Industry Revenue Share (%), by Technology 2025 & 2033
- Figure 4: North America Assisted Reproductive Technology Industry Revenue (billion), by End Users 2025 & 2033
- Figure 5: North America Assisted Reproductive Technology Industry Revenue Share (%), by End Users 2025 & 2033
- Figure 6: North America Assisted Reproductive Technology Industry Revenue (billion), by Country 2025 & 2033
- Figure 7: North America Assisted Reproductive Technology Industry Revenue Share (%), by Country 2025 & 2033
- Figure 8: Europe Assisted Reproductive Technology Industry Revenue (billion), by Technology 2025 & 2033
- Figure 9: Europe Assisted Reproductive Technology Industry Revenue Share (%), by Technology 2025 & 2033
- Figure 10: Europe Assisted Reproductive Technology Industry Revenue (billion), by End Users 2025 & 2033
- Figure 11: Europe Assisted Reproductive Technology Industry Revenue Share (%), by End Users 2025 & 2033
- Figure 12: Europe Assisted Reproductive Technology Industry Revenue (billion), by Country 2025 & 2033
- Figure 13: Europe Assisted Reproductive Technology Industry Revenue Share (%), by Country 2025 & 2033
- Figure 14: Asia Pacific Assisted Reproductive Technology Industry Revenue (billion), by Technology 2025 & 2033
- Figure 15: Asia Pacific Assisted Reproductive Technology Industry Revenue Share (%), by Technology 2025 & 2033
- Figure 16: Asia Pacific Assisted Reproductive Technology Industry Revenue (billion), by End Users 2025 & 2033
- Figure 17: Asia Pacific Assisted Reproductive Technology Industry Revenue Share (%), by End Users 2025 & 2033
- Figure 18: Asia Pacific Assisted Reproductive Technology Industry Revenue (billion), by Country 2025 & 2033
- Figure 19: Asia Pacific Assisted Reproductive Technology Industry Revenue Share (%), by Country 2025 & 2033
- Figure 20: Middle East and Africa Assisted Reproductive Technology Industry Revenue (billion), by Technology 2025 & 2033
- Figure 21: Middle East and Africa Assisted Reproductive Technology Industry Revenue Share (%), by Technology 2025 & 2033
- Figure 22: Middle East and Africa Assisted Reproductive Technology Industry Revenue (billion), by End Users 2025 & 2033
- Figure 23: Middle East and Africa Assisted Reproductive Technology Industry Revenue Share (%), by End Users 2025 & 2033
- Figure 24: Middle East and Africa Assisted Reproductive Technology Industry Revenue (billion), by Country 2025 & 2033
- Figure 25: Middle East and Africa Assisted Reproductive Technology Industry Revenue Share (%), by Country 2025 & 2033
- Figure 26: South America Assisted Reproductive Technology Industry Revenue (billion), by Technology 2025 & 2033
- Figure 27: South America Assisted Reproductive Technology Industry Revenue Share (%), by Technology 2025 & 2033
- Figure 28: South America Assisted Reproductive Technology Industry Revenue (billion), by End Users 2025 & 2033
- Figure 29: South America Assisted Reproductive Technology Industry Revenue Share (%), by End Users 2025 & 2033
- Figure 30: South America Assisted Reproductive Technology Industry Revenue (billion), by Country 2025 & 2033
- Figure 31: South America Assisted Reproductive Technology Industry Revenue Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global Assisted Reproductive Technology Industry Revenue billion Forecast, by Technology 2020 & 2033
- Table 2: Global Assisted Reproductive Technology Industry Revenue billion Forecast, by End Users 2020 & 2033
- Table 3: Global Assisted Reproductive Technology Industry Revenue billion Forecast, by Region 2020 & 2033
- Table 4: Global Assisted Reproductive Technology Industry Revenue billion Forecast, by Technology 2020 & 2033
- Table 5: Global Assisted Reproductive Technology Industry Revenue billion Forecast, by End Users 2020 & 2033
- Table 6: Global Assisted Reproductive Technology Industry Revenue billion Forecast, by Country 2020 & 2033
- Table 7: United States Assisted Reproductive Technology Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 8: Canada Assisted Reproductive Technology Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 9: Mexico Assisted Reproductive Technology Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 10: Global Assisted Reproductive Technology Industry Revenue billion Forecast, by Technology 2020 & 2033
- Table 11: Global Assisted Reproductive Technology Industry Revenue billion Forecast, by End Users 2020 & 2033
- Table 12: Global Assisted Reproductive Technology Industry Revenue billion Forecast, by Country 2020 & 2033
- Table 13: Germany Assisted Reproductive Technology Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 14: United Kingdom Assisted Reproductive Technology Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 15: France Assisted Reproductive Technology Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 16: Italy Assisted Reproductive Technology Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 17: Spain Assisted Reproductive Technology Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 18: Rest of Europe Assisted Reproductive Technology Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 19: Global Assisted Reproductive Technology Industry Revenue billion Forecast, by Technology 2020 & 2033
- Table 20: Global Assisted Reproductive Technology Industry Revenue billion Forecast, by End Users 2020 & 2033
- Table 21: Global Assisted Reproductive Technology Industry Revenue billion Forecast, by Country 2020 & 2033
- Table 22: China Assisted Reproductive Technology Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 23: Japan Assisted Reproductive Technology Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 24: India Assisted Reproductive Technology Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 25: Australia Assisted Reproductive Technology Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 26: South Korea Assisted Reproductive Technology Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 27: Rest of Asia Pacific Assisted Reproductive Technology Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 28: Global Assisted Reproductive Technology Industry Revenue billion Forecast, by Technology 2020 & 2033
- Table 29: Global Assisted Reproductive Technology Industry Revenue billion Forecast, by End Users 2020 & 2033
- Table 30: Global Assisted Reproductive Technology Industry Revenue billion Forecast, by Country 2020 & 2033
- Table 31: GCC Assisted Reproductive Technology Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 32: South Africa Assisted Reproductive Technology Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 33: Rest of Middle East and Africa Assisted Reproductive Technology Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 34: Global Assisted Reproductive Technology Industry Revenue billion Forecast, by Technology 2020 & 2033
- Table 35: Global Assisted Reproductive Technology Industry Revenue billion Forecast, by End Users 2020 & 2033
- Table 36: Global Assisted Reproductive Technology Industry Revenue billion Forecast, by Country 2020 & 2033
- Table 37: Brazil Assisted Reproductive Technology Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 38: Argentina Assisted Reproductive Technology Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 39: Rest of South America Assisted Reproductive Technology Industry Revenue (billion) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Assisted Reproductive Technology Industry?
The projected CAGR is approximately 8.3%.
2. Which companies are prominent players in the Assisted Reproductive Technology Industry?
Key companies in the market include Microm Ltd, Ferring B V, Hamilton Thorne Inc, FUJIFILM Irvine Scientific Inc, OvaScience Inc, Esco Medical, Memmert GmbH + Co KG*List Not Exhaustive, CooperSurgical Inc, Nidacon International AB, Laboratoire CCD, Vitrolife, Bloom IVF Centre.
3. What are the main segments of the Assisted Reproductive Technology Industry?
The market segments include Technology, End Users.
4. Can you provide details about the market size?
The market size is estimated to be USD 37.21 billion as of 2022.
5. What are some drivers contributing to market growth?
Increasing Number of Infertility Cases; Rise in Number of Single Women and Same-sex Couples; Increase in Awareness for IVF and Surrogacy.
6. What are the notable trends driving market growth?
In-Vitro Fertilization (IVF) Segment is Expected to Grow Significantly During the Forecast Period.
7. Are there any restraints impacting market growth?
High Cost and Socio-ethical Issues; Changing Government Regulations.
8. Can you provide examples of recent developments in the market?
February 2023: Bumrungrad International Hospital launched its Fertility Center & IVF Clinic, which delivers holistic reproductive care, from consultation to assisted reproductive technology (ART), for families wanting to conceive.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in billion.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Assisted Reproductive Technology Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Assisted Reproductive Technology Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Assisted Reproductive Technology Industry?
To stay informed about further developments, trends, and reports in the Assisted Reproductive Technology Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence